Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease

This study has been withdrawn prior to enrollment.
(Insufficient enrollment)
Sponsor:
Information provided by (Responsible Party):
Mark Nehler, MD, Colorado Prevention Center
ClinicalTrials.gov Identifier:
NCT00657514
First received: April 8, 2008
Last updated: August 13, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)